Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder in which, via unresolved mechanisms, platelets and megakaryocytes (MKs) are targeted by autoantibodies and/or T cells resulting in increased platelet destruction and impairment of MK function. Over the years, several therapeutic modali...
Main Authors: | Anne-Tess C. Jolink, Vivianne S. Nelson, Martin R. Schipperus, Sufia N. Amini, Gestur Vidarsson, C. Ellen van der Schoot, Leendert Porcelijn, Masja de Haas, Rick Kapur |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/15/3403 |
Similar Items
-
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
by: Anne Zufferey, et al.
Published: (2017-02-01) -
Understanding Immune Thrombocytopenia: Looking Out of the Box
by: Alexandra Schifferli, et al.
Published: (2021-06-01) -
Partial splenic embolization for refractory thrombocytopenia
by: Irwin M. Best
Published: (2011-12-01) -
Emerging Concepts in Immune Thrombocytopenia
by: Maurice Swinkels, et al.
Published: (2018-04-01) -
Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01)